Next Article in Journal
Cytoskeleton Rearrangement in Podocytopathies: An Update
Next Article in Special Issue
The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models
Previous Article in Journal
Editorial for the Special Issue “Advances in the Development of Anticancer Drugs”
Previous Article in Special Issue
Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2024, 25(1), 646; https://doi.org/10.3390/ijms25010646
Action Date Notes Link
article xml file uploaded 4 January 2024 06:40 CET Original file -
article xml uploaded. 4 January 2024 06:40 CET Update https://www.mdpi.com/1422-0067/25/1/646/xml
article pdf uploaded. 4 January 2024 06:40 CET Version of Record https://www.mdpi.com/1422-0067/25/1/646/pdf
article supplementary file uploaded. 4 January 2024 06:40 CET - https://www.mdpi.com/1422-0067/25/1/646#supplementary
article html file updated 4 January 2024 06:42 CET Original file -
article html file updated 24 June 2025 06:34 CEST Update https://www.mdpi.com/1422-0067/25/1/646/html
Back to TopTop